Diaphragm Ultrasound in Critical Care: Current Evidence and Clinical Applications

Abstract

Diaphragm ultrasound has emerged as a valuable, non-invasive tool for assessing diaphragmatic function in critically ill patients. This review synthesizes current evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnosis, treatment, and emerging advances in diaphragm ultrasound. Emphasis is placed on the modality’s practical implications in intensive care, highlighting its role in optimizing patient outcomes, guiding mechanical ventilation strategies, and informing weaning decisions. The review also addresses guideline recommendations and identifies future directions for research and clinical practice.

Introduction

In the critical care setting, respiratory failure remains a leading cause of morbidity and mortality. The diaphragm, as the principal muscle of respiration, plays a pivotal role in maintaining adequate ventilation, particularly in patients requiring mechanical ventilation. Diaphragm dysfunction is increasingly recognized as a determinant of poor outcomes, including prolonged mechanical ventilation, weaning failure, and increased mortality. Ultrasound has become the modality of choice for bedside diaphragm assessment due to its safety, repeatability, and absence of ionizing radiation. This article provides an in-depth overview of diaphragm ultrasound in critical care, integrating the latest research, clinical evidence, and guideline-based approaches.

Epidemiology / Disease Burden

Diaphragm dysfunction is prevalent among critically ill patients, with studies indicating an incidence of 30–60% in those requiring prolonged mechanical ventilation. The burden is particularly high in populations with sepsis, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD). Diaphragm dysfunction contributes significantly to weaning failure, increased ICU length of stay, and healthcare costs. The integration of diaphragm ultrasound into routine ICU practice offers the potential to improve detection and management, thereby reducing the overall disease burden.

Pathophysiology

The pathophysiology of diaphragm dysfunction in critical illness is multifactorial. Key mechanisms include disuse atrophy from mechanical ventilation, systemic inflammation, oxidative stress, and neuromuscular junction impairment. Mechanical ventilation, especially in controlled modes, reduces diaphragmatic workload, leading to rapid muscle fiber atrophy a phenomenon termed ventilator-induced diaphragmatic dysfunction (VIDD). Additional contributors include sepsis-induced myopathy, electrolyte disturbances, and medication effects such as corticosteroids and neuromuscular blockers. Understanding these mechanisms underpins the rationale for early detection and targeted interventions.

Risk Factors

Several risk factors predispose critically ill patients to diaphragm dysfunction. Prolonged mechanical ventilation is the most significant, particularly with controlled ventilation settings. Sepsis, systemic inflammatory response, malnutrition, pre-existing neuromuscular disorders, advanced age, and comorbidities such as COPD and heart failure further increase vulnerability. Additionally, the use of sedatives, corticosteroids, and neuromuscular blocking agents are independently associated with impaired diaphragmatic function. Identifying high-risk individuals facilitates early intervention and may improve patient trajectories.

Clinical Features

Diaphragm dysfunction often presents subclinically, with overt respiratory distress manifesting only in advanced cases. Clinical features include unexplained weaning failure, tachypnea, use of accessory muscles, reduced tidal volumes, and paradoxical abdominal movements. In mechanically ventilated patients, signs may be subtle and masked by ventilatory support. Early identification through imaging and monitoring is essential, as delayed recognition is associated with poorer outcomes and increased complications, including ventilator-associated pneumonia and prolonged ICU stay.

Diagnosis

Diaphragm ultrasound has become the gold standard for non-invasive, bedside evaluation of diaphragmatic structure and function. Key parameters assessed include diaphragmatic thickness, thickening fraction (TF), and excursion during inspiration. A TF <20% or reduced excursion (<1 cm in adults) is highly suggestive of dysfunction. Ultrasound allows dynamic, real-time monitoring, facilitating serial assessments. Other diagnostic modalities, such as fluoroscopy, phrenic nerve conduction studies, and electromyography, are less suitable for routine ICU use due to logistical and safety constraints. The reproducibility and feasibility of ultrasonographic assessment make it a cornerstone of diaphragm monitoring in critical care.

Treatment & Management

Management of diaphragmatic dysfunction revolves around minimizing contributing factors and promoting diaphragmatic activity. Strategies include the use of spontaneous or assisted ventilation modes, early mobilization, optimization of nutrition, and judicious use of sedatives and neuromuscular blockers. Inspiratory muscle training (IMT) and targeted physiotherapy have demonstrated potential in improving diaphragmatic strength and weaning outcomes. In select cases, phrenic nerve pacing or diaphragmatic stimulation may be considered. The integration of ultrasound findings into ventilatory management algorithms improves personalization of care, supporting timely interventions and reducing complications.

Recent Advances / Emerging Therapies

Recent advances in diaphragm ultrasound include the development of automated quantification software and portable ultrasound devices, enhancing accessibility and diagnostic accuracy. Advanced imaging techniques, such as speckle tracking and elastography, are being explored for detailed assessment of diaphragmatic mechanics. Novel interventions, including transcutaneous phrenic nerve stimulation and pharmacological agents targeting muscle atrophy, are under investigation. Ongoing research is focused on refining ultrasound protocols and establishing standardized thresholds for diagnosis and prognosis, which will enable broader adoption and improved inter-operator reliability.

Guideline Recommendations

Major critical care societies now endorse the use of diaphragm ultrasound for the assessment of ventilatory muscle function. Guidelines recommend routine evaluation of diaphragmatic thickness and excursion in patients at risk of weaning failure or prolonged mechanical ventilation. Ultrasound findings should be integrated with clinical assessment and other respiratory parameters to guide ventilatory management and inform weaning readiness. Continuous education and competency-based ultrasound training are also emphasized to ensure accurate interpretation and application in clinical practice.

Conclusion

Diaphragm ultrasound has revolutionized the bedside assessment of respiratory muscle function in critical care. It provides actionable insights into diaphragmatic structure and performance, enabling early identification of dysfunction and tailored interventions. With expanding evidence and technological advancements, diaphragm ultrasound is set to become an integral component of critical care monitoring, supporting improved patient outcomes through precision medicine. Continued research, guideline refinement, and education are essential to maximize its clinical impact and promote widespread adoption in intensive care units globally.